“…The literature presents variable and partly conflicting results concerning the use of clinical data to predict response to MPH. Age, weight, gender, comorbid anxiety or oppositional defiant disorder, IQ, academic achievement, disease duration, severity of symptoms, level of maternal ADHD symptoms, and prior atomoxetine use have all been shown to have some predictive effect (Buitelaar et al, 2011; Buitelaar, Van Der Gaag, Swaab-barnkvhld, & Kuipkr, 1995; Chazan et al, 2011; Fredriksen, Dahl, Martinsen, Klungsoyr, Haavik, et al, 2014; Ishii-Takahashi et al, 2015; Johnston et al, 2015; Setyawan et al, 2015; Treuer et al, 2014; Wong et al, 2017). It has been difficult to predict treatment response to stimulants using neuropsychological tests in ADHD patient as well, and results from these studies have also been conflicting (Coghill et al, 2007; Wong et al, 2017).…”